Target intelligence / Profile preview

Intestinal microbiota modulation

Molecular classification
Other
01

Overview

Intestinal microbiota modulation refers to the deliberate alteration—through dietary changes, supplementation with probiotics/prebiotics, antibiotics, bacteriophage therapy, fecal microbiota transplantation, or other interventions—of the composition and/or activity of the complex microbial communities residing within the gastrointestinal tract. The goal is typically to restore balance (“eubiosis”) when dysbiosis has occurred due to disease states such as infections, inflammatory disorders, metabolic syndrome, neurodegenerative diseases like Alzheimer’s disease, and even psychological stress-related conditions. These interventions can influence a wide range of physiological processes including nutrient metabolism; maintenance and repair of the intestinal barrier; regulation/modulation of local and systemic immune responses; production/absorption/metabolism of key metabolites such as short-chain fatty acids; communication along the gut-brain axis; resistance against pathogen colonization; and overall host health outcomes. While not a single molecular target but rather an ecosystem-level intervention strategy affecting many molecular pathways simultaneously—and thus not considered a canonical therapeutic “target” like a receptor or enzyme—the concept is central to emerging therapies in gastroenterology and beyond.[1][2][3][4] **Note:** "Intestinal microbiota modulation" is not itself a molecule/receptor/therapeutic target but describes an intervention strategy aimed at altering an entire biological system. It does not fit standard definitions for drug targets such as receptors or enzymes.[1][2]

Other names
Gut microbiota modulationMicrobiome modulationMicrobiota manipulationModulation of gut microbial community
02

Mechanism of action

Restoration or alteration of microbial community composition and function through supplementation or transplantation; Enhancement of beneficial metabolite production by commensal bacteria; Suppression or displacement of pathogenic organisms via competitive exclusion or direct antagonism

03

Biological functions

Regulation of immune responseMetabolic homeostasisMaintenance of intestinal barrier functionModulation of inflammationNutrient metabolismInteraction with the gut-brain axis
04

Disease associations

Inflammation (e.g., inflammatory bowel disease)Infection (e.g., Clostridioides difficile infection)Neurodegenerative disease (e.g., Alzheimer’s disease)Metabolic syndrome and related disordersPsychological conditions (via stress and gut-brain axis)
05

Safety considerations

Risk of infection transmission with fecal microbiota transplantationUnpredictable host responses due to individual variability in baseline microbiome compositionPotential for adverse metabolic or immune effects if dysbiosis is induced rather than corrected
06

Interacting drugs

Probiotics (various strains, e.g. Bifidobacterium adolescentis, Akkermansia muciniphila)

4 more in the full profile.

07

Biomarkers

Microbial diversity indices (Shannon index, etc.)Abundance/proportion of specific taxa (e.g. Akkermansia, Bifidobacterium)Levels of short-chain fatty acids in stool/plasmaMarkers for intestinal permeability/tight junction proteins

Beyond the preview

Go deeper on Intestinal microbiota modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal microbiota modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call